REG - GSK PLC - Director/PDMR Shareholding

RNS Number : 4605H GSK PLC 13 November 2025 GSK plc (the 'Company')Transaction notification1.Details of PDMR/person closely associated with them ('PCA')a)NameEmma Walmsleyb)Position/statusChief Executive Officerc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameJulie Brownb)Position/statusChief Financial Officerc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameJames Fordb)Position/statusSVP and Group General Counsel, Legal and Compliancec)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameSally Jacksonb)Position/statusSVP, Global Communications and CEO Officec)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameDavid Redfernb)Position/statusPresident, Corporate Developmentc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14206 (partnership shares)£18.14206 (matching shares)d)Aggregated informationAggregated volume Price12 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameRegis Simardb)Position/statusPresident, Global Supply Chainc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NamePhilip Thomsonb)Position/statusPresident, Global Affairsc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameDeborah Waterhouseb)Position/statusCEO, ViiV Healthcare and President, Global Health, GSKc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)1.Details of PDMR/person closely associated with them ('PCA')a)NameVictoria Whyteb)Position/statusSVP & Company Secretaryc)Initial notification/amendmentInitial notification2.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameGSK plcb)LEI5493000HZTVUYLO1D7933.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducteda)Description of the financial instrumentOrdinary shares of 31 ¼ pence each ('Ordinary Shares')ISIN: GB00BN7SWP63b)Nature of the transactionAcquisition of Ordinary Shares under the Company's Share Reward Planc)Price(s) and volume(s)Price(s)Volume(s)£18.14207 (partnership shares)£18.14207 (matching shares)d)Aggregated informationAggregated volume Price14 Ordinary Shares£18.1420e)Date of the transaction2025-11-11f)Place of the transactionLondon Stock Exchange (XLON)This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHFFUFFDEISEIF